Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 29, 2012 | March 02, 2012 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | November 19, 2021 | November 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 29, 2012 · Filed March 02, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 144,311 |
Ending reported balance
After 2012-03-01 transaction · row 24
24 source rows · reconciled sequenceRow 1 · 2012-02-29 · Sale · Disposed 4,900 · Balance 220,896 Row 2 · 2012-02-29 · Sale · Disposed 5,750 · Balance 215,146 Row 3 · 2012-02-29 · Sale · Disposed 700 · Balance 214,446 Row 4 · 2012-02-29 · Sale · Disposed 4,115 · Balance 210,331 Row 5 · 2012-02-29 · Sale · Disposed 200 · Balance 210,131 Row 6 · 2012-02-29 · Sale · Disposed 15,135 · Balance 194,996 Row 7 · 2012-02-29 · Sale · Disposed 12,318 · Balance 182,678 Row 8 · 2012-02-29 · Sale · Disposed 2,800 · Balance 179,878 Row 9 · 2012-02-29 · Sale · Disposed 2,300 · Balance 177,578 Row 10 · 2012-02-29 · Sale · Disposed 4,403 · Balance 173,175 Row 11 · 2012-02-29 · Sale · Disposed 200 · Balance 172,975 Row 12 · 2012-02-29 · Sale · Disposed 3,697 · Balance 169,278 Row 13 · 2012-02-29 · Sale · Disposed 2,200 · Balance 167,078 Row 14 · 2012-02-29 · Sale · Disposed 100 · Balance 166,978 Row 15 · 2012-02-29 · Sale · Disposed 1,560 · Balance 165,418 Row 16 · 2012-02-29 · Sale · Disposed 100 · Balance 165,318 Row 17 · 2012-02-29 · Sale · Disposed 100 · Balance 165,218 Row 18 · 2012-02-29 · Sale · Disposed 4,300 · Balance 160,918 Row 19 · 2012-02-29 · Sale · Disposed 700 · Balance 160,218 Row 20 · 2012-02-29 · Sale · Disposed 907 · Balance 159,311 Row 21 · 2012-03-01 · Sale · Disposed 3,737 · Balance 155,574 Row 22 · 2012-03-01 · Sale · Disposed 7,000 · Balance 148,574 Row 23 · 2012-03-01 · Sale · Disposed 100 · Balance 148,474 Row 24 · 2012-03-01 · Sale · Disposed 4,163 · Balance 144,311 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 6,660 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 25
Holding and transaction disclosures are not merged.
1 source rowRow 25 · Balance 6,660 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife | 20,400 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 26
Holding and transaction disclosures are not merged.
1 source rowRow 26 · Balance 20,400 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 27
Holding and transaction disclosures are not merged.
1 source rowRow 27 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 28
Holding and transaction disclosures are not merged.
1 source rowRow 28 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012.
F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date November 19, 2021 · Filed November 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 26,123 |
Reported balance
After 2021-11-19 transaction · row 1
1 source rowRow 1 · 2021-11-19 · Grant · Acquired 4,271 · Balance 26,123 F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $45.49 | $18,194.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,698 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $45.48 | $9,096.50 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,098 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,800 | $45.48 | $218,304.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,298 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $45.48 | $59,117.50 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,098 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,400 | $45.47 | $427,418.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,398 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,500 | $45.47 | $68,203.50 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,798 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $45.47 | $31,826.90 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,298 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,000 | $45.47 | $318,255.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,998 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 25,602 | $45.46 | $1,163,866.92 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,998 Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 53,202 | $45.45 | $2,417,967.06 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.27 | $4,527.15 |
DisclosureSEC source: 0001179110-11-001591 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,398 Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.27 | $4,527.14 |
DisclosureSEC source: 0001179110-11-001591 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,498 Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 8,400 | $45.27 | $380,276.40 |
DisclosureSEC source: 0001179110-11-001591 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,598 Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.27 | $4,527.06 |
DisclosureSEC source: 0001179110-11-001591 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,998 Read SEC document |
| January 31, 2011 Filed Feb 1, 2011 22:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,300 | $45.27 | $285,201.00 |
DisclosureSEC source: 0001179110-11-001591 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,098 Read SEC document |
| November 30, 2010 Filed Dec 15, 2010 22:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-017576 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,398 Read SEC document |
| August 12, 2010 Filed Sep 3, 2010 21:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-013497 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,523 Read SEC document |
| June 03, 2010 Filed Jul 23, 2010 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011861 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 150 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. Read SEC document |
| June 03, 2010 Filed Jul 23, 2010 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011861 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 150 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. Read SEC document |
| June 03, 2010 Filed Jul 23, 2010 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011861 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 20,000 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. Read SEC document |
| June 03, 2010 Filed Jul 23, 2010 22:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 20,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011861 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,598 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $47.48 | $4,748.06 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,798 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $47.48 | $9,496.08 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,898 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $47.48 | $4,748.03 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,098 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $47.48 | $4,748.02 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,198 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,600 | $47.48 | $455,817.60 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,298 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,700 | $47.48 | $223,156.00 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,898 Read SEC document |
| June 01, 2010 Filed Jun 3, 2010 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $47.48 | $9,496.28 |
DisclosureSEC source: 0001179110-10-009862 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,598 Read SEC document |
| May 01, 2010 Filed May 4, 2010 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,412 | $51.16 | $72,237.92 |
DisclosureSEC source: 0001179110-10-007825 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,798 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,500 | $54.12 | $514,140.00 |
DisclosureSEC source: 0001179110-10-004236 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,210 Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value · Derivative | 33,500 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001179110-10-003596 · edgar.xml · derivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Shares · 33,500 shares Expires 2020-02-18 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,167 on 2/19/2011, 11,166 on 2/19/2012, and 11,167 on 2/19/2013. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003596 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,710 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 22,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003596 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,710 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $54.62 | $27,311.00 |
DisclosureSEC source: 0001179110-10-003164 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,810 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $54.62 | $65,545.20 |
DisclosureSEC source: 0001179110-10-003164 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,310 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,551 | $53.93 | $299,365.43 |
DisclosureSEC source: 0001179110-10-003164 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,560 Read SEC document |
| February 09, 2010 Filed Feb 18, 2010 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003164 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,510 Read SEC document |
| December 29, 2009 Filed Dec 30, 2009 22:17 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,275 | $54.53 | $69,525.75 |
DisclosureSEC source: 0001179110-09-017579 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,111 Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 36,449 | $0.00 Strike: $53.92 | $0.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · derivative · entry 12 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,449 Underlying: Common Shares · 36,449 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 42,561 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · derivative · entry 11 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 42,561 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 18,564 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · derivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 18,564 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 36,449 | $54.10 | $1,971,963.80 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,606 Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 684 | $54.12 | $37,018.08 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,055 Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.11 | $10,822.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,739 Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 16,380 | $54.10 | $886,158.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,939 Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $54.13 | $70,369.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,319 Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 42,561 | $41.03 | $1,746,350.18 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 18,564 | $51.91 | $963,657.24 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2009 Filed Dec 24, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 220 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-09-017421 · edgar.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,386 Read SEC document |
| November 12, 2009 Filed Jul 23, 2010 22:04 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011860 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 50 F1 · shares: The Form 4 originally filed by the reporting person on December 23, 2009, is hereby amended to show the receipt by two of his daughters of a gift of 50 shares each. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his daughters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.